Rankings
▼
Calendar
PMVP Q4 2019 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PMVP
PMV Pharmaceuticals, Inc.
$84M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.23
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$239,000
Balance Sheet
Total Assets
$103M
Total Liabilities
$174M
Stockholders' Equity
-$70M
Cash & Equivalents
$73M
← FY 2019
All Quarters
Q1 2020 →